IL6 and inflammatory bowel disease: Statistical analysis reveals that administering B. bifidum, particularly in the G5 group, notably decreased IL-6 and TNF-α expression levels compared to the G2 group, resulting in a significant amelioration of IBD (P ≥ 0.0002).